Active Ingredient History
Dexrazoxane is a cardioprotective drug used in patients with breast cancer to reduce cardiomyopathy associated with doxorubicin administration. Dexrazoxane is believed to act by two mechanisms: it inhibits DNA topoisomerase II and acts as a chelator for iron ions. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Breast Neoplasms (approved 1995)
Anthracyclines (Phase 2/Phase 3)
Bone Marrow Cells (Phase 2)
Breast Neoplasms (Phase 3)
Burkitt Lymphoma (Phase 1)
Cardiotoxicity (Phase 3)
Extravasation of Diagnostic and Therapeutic Materials (Phase 2/Phase 3)
Fibrosarcoma (Phase 2)
Ganglioneuroblastoma (Phase 3)
Healthy Volunteers (Phase 4)
Heart Defects, Congenital (Phase 1)
Hemangiosarcoma (Phase 2)
Hodgkin Disease (Phase 1)
Inflammatory Breast Neoplasms (Phase 3)
Intraocular Lymphoma (Phase 1)
Leiomyosarcoma (Phase 2)
Leukemia (Phase 3)
Leukemia, Hairy Cell (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Liposarcoma (Phase 2)
Lung Neoplasms (Phase 1)
Lymphoma (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 1)
Lymphoma, Large-Cell, Anaplastic (Phase 1)
Lymphoma, Large-Cell, Immunoblastic (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1)
Lymphoma, T-Cell (Phase 1)
Lymphoma, T-Cell, Peripheral (Phase 1)
Lymphomatoid Granulomatosis (Phase 1)
Multiple Sclerosis (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Neoplasms (Phase 2)
Neuroblastoma (Phase 3)
Neurofibrosarcoma (Phase 2)
Osteosarcoma (Phase 1)
Rhabdomyosarcoma (Phase 2)
Sarcoma (Phase 3)
Sarcoma, Ewing (Phase 2)
Sarcoma, Myeloid (Phase 2)
Sarcoma, Synovial (Phase 2)
Sezary Syndrome (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue